JAM
RGNX icon

Jupiter Asset Management’s Regenxbio RGNX Stock Holding History

Jupiter Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-44,158
Closed -$793K – 514
2023
Q4 		$793K Sell
44,158
-29,888
-40% -$526K 0.01% 401
2023
Q3 		$1.22M Hold
74,046
– – 0.01% 384
2023
Q2 		$1.48M Hold
74,046
– – 0.02% 399
2023
Q1 		$1.4M Buy
+74,046
New +$1.64M 0.02% 318

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Jupiter Asset Management's RGNX Position: Q1 2024 in Review

Jupiter Asset Management sold out of Regenxbio (RGNX) in Q1 2024, closing a stake of 44,158 shares — an estimated $793K sold.

Jupiter Asset Management first reported a position in RGNX in Q1 2023 and held it in 4 quarters. The position peaked at $1.48M in Q2 2023. 188 funds tracked by Wall St. Rank hold RGNX as of Q1 2024.

  • Jupiter Asset Management reported no remaining Regenxbio position as of Q1 2024 after selling out during the quarter.
  • Jupiter Asset Management sold 44,158 Regenxbio shares in Q1 2024, an estimated $793K.
  • Jupiter Asset Management first reported a position in Regenxbio in Q1 2023 and held it in 4 quarters.
  • Jupiter Asset Management's Regenxbio position peaked at $1.48M in Q2 2023.
  • 188 funds tracked by Wall St. Rank held Regenxbio as of Q1 2024.

Based on Jupiter Asset Management's 13F filing for Q1 2024, filed 10 May 2024.